Equities

Novacyt SA

NCYT:LSE

Novacyt SA

Health CareMedical Equipment and Services
  • Price (GBX)34.45
  • Today's Change-0.15 / -0.43%
  • Shares traded27.79k
  • 1 Year change-31.65%
  • Beta0.1827
Data delayed at least 20 minutes, as of Feb 06 2026 14:23 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Income statement information is not available for Novacyt SA.
Gross margin63.35%
Net profit margin-145.32%
Operating margin-143.35%
Return on assets-34.20%
Return on equity-49.90%
Return on investment-39.09%
More ▼

Cash flow in GBPView more

In 2024, cash reserves at Novacyt SA fell by 13.60m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 9.82m for operations while cash used for investing totalled 1.86m.
Cash flow per share-0.3398
Price/Cash flow per share--
Book value per share0.6667
Tangible book value per share0.3544
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.